Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the Western
world and its incidence is increasing rapidly. NAFLD is a spectrum ranging from simple …

Non-alcoholic fatty liver disease (NAFLD) ranges from simple steatosis to nonalcoholic
steatohepatitis (NASH), leading to fibrosis and potentially cirrhosis, and it is one of the most …

Non-alcoholic fatty liver disease or NAFLD is a chronic liver condition characterized by
hepatic steatosis and associated with insulin resistance and type 2 diabetes mellitus …

The clinicopathologic spectrum of nonalcoholic fatty liver disease (NAFLD) ranges from
simple steatosis to nonalcoholic steatohepatitis (NASH). Simple steatosis has a relatively …

Non‐alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
Western world. It is closely associated with metabolic syndrome. The alarming epidemics of …

Nonalcoholic fatty liver disease (NAFLD) has emerged as the most common chronic liver
disease worldwide with a reported prevalence ranging 6–33%, depending on the studied …

Non-alcoholic fatty liver disease (NAFLD) is now the most frequent chronic liver disease that
occurs across all age groups and is recognized to occur in 14%-30% of the general …

Non-alcoholic fatty liver disease (NAFLD) encompasses the simple steatosis to more
progressive steatosis with associated hepatitis, fibrosis, cirrhosis, and in some cases …

Nonalcoholic fatty liver disease is now recognized as the most common liver disease in the
United States, with a prevalence of approximately 5% in the general population and up to …

Nonalcoholic fatty liver disease may be the most common liver disease in the United States,
with a high prevalence in the obese, type 2 diabetic population, and it is probably …